CLVS - Clovis Oncology Inc
Previous close
0.0812
0 0%
Share volume: 0
Last Updated: Tue 20 Dec 2022 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.08
0.00
0.00%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
Report Date | 2022-05-05 | 2022-08-08 | 2022-11-09 | |
Total revenue | 34.247 M | 32.143 M | 30.663 M | |
Cost of revenue | 8.070 M | 7.872 M | 7.265 M | |
Gross profit | 26.177 M | 24.271 M | 23.398 M | |
-7.28% | -3.60% | |||
Operating expenses | 71.463 M | 69.016 M | 61.167 M | |
Selling general and admin | 29.213 M | 32.590 M | 30.380 M | |
Research and development | 42.250 M | 36.426 M | 30.787 M | |
Total expenses | 84.606 M | 91.524 M | 74.898 M | |
8.18% | -18.17% | |||
Operating income | -50.359 M | -59.381 M | -44.235 M | |
Ebit | -50.359 M | -59.381 M | -44.235 M | |
Pretax income | -60.289 M | -71.373 M | -55.979 M | |
18.38% | -21.57% | |||
Income tax | -120.000 K | -41.000 K | 35.000 K | |
Net income basic | -60.169 M | -71.332 M | -56.014 M | |
-18.55% | 21.47% | |||
Net income | -60.169 M | -71.332 M | -56.014 M | |
-18.55% | 21.47% |